Clinical trial

Morning Versus Bedtime Dosing of Antihypertensive Medication

NCT05089448

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2021-01-28

PhasePHASE4

Study timeline

Study start (actual)2021-01-28Date precision: day

Registry last updated2025-01-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hypertensionunresolved

Blood Pressureunresolved

Drug Useunresolved

Interventions

Alisartan, Amlodipine besylateDRUG

Sponsors & collaborators

Yan Lilead sponsor

Mapped research locations

ShanghaiShanghai Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05089448 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.